Unraveling the precise role of PPARγ in the complex tissue response in cancer could be paramount for a rational design of new therapy schemes that take advantage of the potent antitumor action of PPARγ agonists targeting both epithelial and stromal cells within a breast tumor microenvironment. This evidence concerns the gene PPARG and cancer.